Page last updated: 2024-09-02

tadalafil and Cerebral Microangiopathies

tadalafil has been researched along with Cerebral Microangiopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrick, TR; Betteridge, S; Clarke, N; Haig, CE; Hainsworth, AH; Howe, FA; Isaacs, JD; Khan, U; Kruuse, C; Madigan, JB; Moynihan, B; Pauls, MMH; Pereira, AC; Rolfe, D; Rostrup, E; Trippier, S	1

Trials

1 trial(s) available for tadalafil and Cerebral Microangiopathies

Article	Year
Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trial. Trials, 2017, 05-22, Volume: 18, Issue:1 Topics: Administration, Oral; Cerebral Small Vessel Diseases; Cerebrovascular Circulation; Clinical Protocols; Cognition; Cross-Over Studies; Double-Blind Method; Humans; London; Magnetic Resonance Imaging; Neuropsychological Tests; Perfusion Imaging; Phosphodiesterase 5 Inhibitors; Predictive Value of Tests; Sample Size; Spin Labels; Tadalafil; Time Factors; Treatment Outcome; Vasodilator Agents	2017

Article

Year

Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trial.

Trials, 2017, 05-22, Volume: 18, Issue:1

Topics: Administration, Oral; Cerebral Small Vessel Diseases; Cerebrovascular Circulation; Clinical Protocols; Cognition; Cross-Over Studies; Double-Blind Method; Humans; London; Magnetic Resonance Imaging; Neuropsychological Tests; Perfusion Imaging; Phosphodiesterase 5 Inhibitors; Predictive Value of Tests; Sample Size; Spin Labels; Tadalafil; Time Factors; Treatment Outcome; Vasodilator Agents

2017